Abstract:Hanrui Wang, 1– 4, &ast Xiaoyu Song, 1– 4, &ast Yao Wang, 1– 4 Ting Yang, 1– 4 Wanchen Liu, 1– 4 Yakui Mou, 1– 4, &ast Chao Ren, 1– 5 Xicheng Song 1– 4 1 Department of Otorhinolaryngology, Head and Neck Surgery, Yantai Yuhuangding Hospital, Qingdao University, Yantai, People's Republic of China; 2 Shandong Provincial Key Laboratory of Neuroimmune Interaction and Regulation, Yantai Yuhuangding Hospital, Yantai, People's Republic of China; 3 Shandong Provincial Clinical Research Center for Otorhinolaryngologic Diseases, Yantai Yuhuangding Hospital, Yantai, People's Republic of China; 4 Yantai Key Laboratory of Otorhinolaryngologic Diseases, Yantai Yuhuangding Hospital, Qingdao University, Yantai, People's Republic of China; 5 Department of Neurology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xicheng Song; Chao Ren, Yantai Yuhuangding Hospital, Qingdao University, No. 20, East Road, Zhifu District, Yantai, 264000, People's Republic of China, Tel +86535 6691999, Fax +86535 6240341, Email ; Background: The nasal mucosal epithelial barrier is the primary site of allergic rhinitis (AR). Interleukin-1β (IL-1β), as a crucial factor in immune inflammation, not only plays a crucial role in hypersensitivity reactions but also affects the digestive mucosa and skin epithelial barrier. However, the role of IL-1β in the nasal mucosal epithelial barrier in AR has not been reported, and this study aimed to investigate the effect and possible mechanisms involved. Methods: Dermatophagoides pteronyssinus 1 was used as an allergen to construct an AR mouse model and stimulate human nasal mucosal epithelial cells (HNEpCs) and observe the expression changes of IL-1β and epithelial barrier indicators CLDN1 and OCLN in mouse nasal mucosa and HNEpCs. Then, the possible mechanisms of action were explored via exogenous IL-1β stimulation and pharmacological inhibition of IL-1β or its receptor interleukin-1 receptor type 1 (IL-1R1). Results: The results showed that Dermatophagoides pteronyssinus 1-primed mouse nasal mucosa or human HENpCs had increased expression of IL-1β and decreased CLDN1 and OCLN, and IL-1β could directly lead to reduced expression of epithelial barrier indexes in HNEpCs. In addition, inhibition of IL-1β or IL-1R1 can effectively alleviate the damage to the epithelial barrier. Conclusion: IL-1β has a destructive effect on the nasal mucosal epithelial barrier in AR, and inhibition of IL-1β or its receptor IL-1R1 can effectively protect the nasal mucosal barrier. IL-1β is a potential target for the treatment of AR. Keywords: interleukin-1β, allergic rhinitis, nasal mucous membrane, epithelial barrier, DerP1 Allergic rhinitis (AR) is a localized chronic, non-infectious inflammation of the nasal mucosa induced by contact with individual-specific allergens. Its symptoms seriously affect people's normal lives and work-study efficiency. 1 The epithelial cells of the normal nasal mucosa, which are in close contact with the external environment, act as a physiological barrier to prevent pathogenic bacteria from invading the area. When the barrier is damaged, allergens penetrate deeper into the inter-epithelial and subepithelial regions of the mucosa. This stimulates allergy-related effector cells or factors, which will promote the development of type I hypersensitivity reactions. 2,3 Furthermore, the increase of those allergy-related factors also contributes to the damage of the epithelial barrier, ultimately leading to the formation of a vicious circle of "physical barrier destruction-immune imbalance" in the allergen-stimulated nasal mucosa, which is a key link that is frequently disregarded. 4 Research on the structure and function of the mucosal barrier has advanced owing to improvements in etch electron microscopy, transmission electron microscopy, and other biotechnological techniques. Several studies have confirmed that the dynamics of the nasal mucosal epithelial barrier are implicated in almost the entire pathophysiological process of the nasal immune response in AR. 5,6 The intact epithelial barrier defends against allergen invasion by allergens that seep in owing to the structural and functional impairment of the nasal barrier and finally to the immune-inflammatory response of the body rupturing the tight junctions (TJs) between epithelial cells. 7,8 Although the "epithelial barrier hypothesis" has been mentioned frequently during the investigation of AR, its specific mechanism of action has -Abstract Truncated-

The nasal basal cell population shifts towards a diseased phenotype with impaired barrier formation capacity in allergic rhinitis

Allergic inflammatory memory in human respiratory epithelial progenitor cells

Physical and immunological barrier of human primary nasal epithelial cells from non-allergic and allergic donors

Neuroimmune communication in allergic rhinitis

Responses of Well-differentiated Human Sinonasal Epithelial Cells to Allergen Exposure and Environmental Pollution in Chronic Rhinosinusitis

Rare presence and function of neuroendocrine cells in the nasal mucosa

B Lineage Cells and IgE in Allergic Rhinitis and CRSwNP and the Role of Omalizumab Treatment

Single-cell profiling identifies mechanisms of inflammatory heterogeneity in chronic rhinosinusitis

Ciliated Cells Express a Novel Pattern of Brain-Derived Neurotrophic Factor in Allergic Rhinitis

Nasal hyperreactivity in allergic rhinitis and chronic rhinosinusitis with polyps: a role for neuronal pathways

Comprehensive Analysis Reveals Hub Genes Associated with Immune Cell Infiltration in Allergic Rhinitis

Interleukin 1β Mediates the Pathogenesis of Nasal Mucosal Epithelial Barrier Dysfunction in Allergic Rhinitis

Characteristics of ectopic alveolar basal cells relative to airway basal cells in fibrosis

Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation

Allergic rhinitis: past, present and the future

CD169+ Macrophages Mediate the Immune Response of Allergic Rhinitis Through the Keap1/Nrf2/HO-1 Axis

The multi-omics single-cell landscape of sinus mucosa in uncontrolled severe chronic rhinosinusitis with nasal polyps

Altered Microrna Expression Profiles of Extracellular Vesicles in Nasal Mucus from Patients with Allergic Rhinitis

Role of Th2, Th17 and Treg Cells and relevant cytokines in pathogenesis of allergic rhinitis

Human Airway Basal Cells Undergo Reversible Squamous Differentiation and Reshape Innate Immunity

Increased CD123 + HLA-DR− Granulocytes in Allergic Rhinitis and Influence of Allergens on Expression of Cell Membrane Markers